Morphine Sulfate Market top key players market segments cost and revenue analysis to 2025

on

18 December 2018: Global Morphine Sulfate (CAS 64-61-3) Market is expected to rise at a significant CAGR in the forthcoming years. The dosage for Morphine sulfate (CAS 64-31-3) is dependent on the patient’s medical conditions and response to the treatment. The does should not be increased abruptly or the intake should not be exceeded than the prescribed period. Morphine sulfate tablets are controlled-release tables with ingredients like cetostearyl alcohol, hydroxyethyl cellulose, hypromellose, polyethylene glycol, talc, titanium dioxide and magnesium stearate.
Commercial market driving factors responsible for the growth of morphine sulfate market includes demand for painkiller antibiotics and other health conditions. However, the concerned side-effects and health hazards are likely to impede the market growth. Also, ban in some countries on using morphine contributes as a restraining factor.
Based on segmentation by product, the morphine sulfate (CAS 64-31-3) includes powder and pills. Pills dominate the segment owing to growth in prevalence of painkiller and antibiotics. Based on segmentation by end-user, the morphine sulfate (CAS 64-31-3) includes injection and capsule. Capsule dominates the market segment owing to rise in demand for solid oral dosage.
Geographically, morphine sulfate (CAS 64-31-3) market spans North America, Latin America, Europe, Asia-Pacifica, Middle-East and Africa. APAC market dominate the global market owing to presence of enormous pool of customers and rise in medical infrastructure. China, India, Japan, South Korea and Taiwan are leading in the manufacture of the prescribed tablet. North America and Europe market are also expected to grow at a steady CAGR in the forthcoming years owing to ban on morphine in some countries due to its bizarre nature and mode of intake. MEA regions are also expected to rise at a steady CAGR owing to low demand and developing medical infrastructure.
The key players in the morphine sulfate (CAS 64-31-3) market include Mallinckrodt Pharmaceuticals, Purdue Pharma, Cepia-Sanofi, Macfarlan Smith, SUN PHARMA, Qinghai Pharmaceutical, Taj Pharmaceutical and Northeast Pharm.

Comments

Post a Comment